Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Maes, Michael, Kubera, Marta, Uytterhoeven, Marc et al. · Medical science monitor : international medical journal of experimental and clinical research · 2011 · DOI
Quick Summary
This study measured two markers of oxidative stress (damage caused by harmful molecules in the body) in people with ME/CFS compared to healthy people. Researchers found that ME/CFS patients had significantly higher levels of plasma peroxides—harmful molecules that damage cells. These findings suggest that oxidative stress may play a role in ME/CFS, which could help explain some of the illness's symptoms.
Why It Matters
Identifying objective biomarkers like elevated plasma peroxides could improve ME/CFS diagnosis and help validate the biological basis of the illness. Understanding that oxidative stress is increased in ME/CFS may point toward potential therapeutic targets and support the recognition of ME/CFS as an organic disease rather than purely psychological.
Observed Findings
Plasma peroxide concentrations were significantly higher in ME/CFS patients compared to healthy controls.
Serum oxLDL antibody levels showed a trend toward elevation in ME/CFS patients, though this did not reach full statistical significance.
Both biomarkers (plasma peroxides and oxLDL antibodies) contributed significantly to distinguishing ME/CFS patients from normal controls.
Plasma peroxide and serum oxLDL antibody levels were significantly correlated with at least one symptom on the Fibromyalgia and Chronic Fatigue Syndrome Rating Scale.
Inferred Conclusions
ME/CFS is characterized by increased oxidative stress, as demonstrated by elevated plasma peroxide levels.
Oxidative stress markers may serve as objective biomarkers for ME/CFS diagnosis and severity assessment.
Oxidative and nitrosative stress pathways are activated in ME/CFS, supporting the broader immune and inflammatory dysfunction model of the disease.
Remaining Questions
Do oxidative stress levels change over the course of ME/CFS illness, or are they stable baseline markers?
What causes the increased oxidative stress in ME/CFS—is it from immune activation, mitochondrial dysfunction, reduced antioxidant defenses, or another source?
What This Study Does Not Prove
This study does not prove that oxidative stress causes ME/CFS symptoms or is the primary mechanism of disease—only that it is associated with the condition. The cross-sectional design cannot establish whether oxidative stress precedes ME/CFS or results from it. The findings also do not indicate whether reducing oxidative stress would improve patient outcomes.